Nifurquinazol

This classification denotes an antimicrobial with the molecular formula C16H16N4O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 44E5RRL600, chemically known as 2,2-((2-(5-nitro-2-furyl)-4-quinazolinyl)imino)diethanol but more generally known as nifurquinazol, which bears US NIH Compound Identifier 21139. European Medicines Agency schedules Nifurquinazol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09276MIG. The term NIFURQUINAZOL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 22, No. 10, 1968, List 8). NIFURQUINAZOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule nifurquinazol under HS 29349990 and SITC 51579. As of Q4 2014, NIFURQUINAZOL remains US FDA's Preferred Term for this commodity. Nifurquinazol bears US NLM identifiers UMLS ID C2983987 and NCI Concept Code C91015. SMILES: OCCN(C1NC(NC2C1CCCC2)C1OC([N](=O)O)CC1)CCO.